 prolong treatment children chronic hepat recombin alpha studi prospect studi efficaci toler alpha-interferon children biopsy-proven hbsag/hbeag/hbv-dna-posit anti-delta-neg chronic hepat patient alpha inf MU im time month treatment patient group patient ifn mark decreas negativ hbv-dna treatment end studi month patient hbv-dna hbeab month disappear hbv-dna normal aminotransferas valu control group patient spontan clearanc hbv-dna convers hbeab normal aminotransferas level patient febril reaction first month treatment dose ifn patient persist intoler patient decreas viral replic initi biochem histolog activ nonrespond data suggest ifn treatment progress chronic hepat children histori acut hepat activ chronic diseas